Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

NEUROIMAGE, published by Academic Press Inc Elsevier Science, is a leading international journal dedicated to advancing the fields of cognitive neuroscience and neurology. With an impressive impact factor that places it in the Q1 category for both disciplines, NEUROIMAGE stands at the forefront of disseminating high-quality research that employs advanced imaging methods to elucidate the workings of the human brain. As a pivotal platform since its inception in 1992, this journal has continued to thrive, embracing Open Access publishing since 2020 to ensure wider dissemination and accessibility of cutting-edge findings. With a Scopus rank of 7th in cognitive neuroscience and 13th in neurology, and situated in the 94th and 93rd percentiles respectively, NEUROIMAGE serves as an invaluable resource for researchers, professionals, and students alike seeking to explore the intricate relationships between brain structure and function. For more information, please visit their office at 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495.

Brain and Behavior is a premier open-access journal published by WILEY, dedicated to advancing the field of Behavioral Neuroscience. With its ISSN 2162-3279, the journal has established itself as a vital resource for researchers, professionals, and students alike, fostering the dissemination of cutting-edge research since its inception in 2011. Renowned for its rigorous peer-review process, it enjoys a commendable Q2 ranking within the field, reflecting its impactful contributions and relevance in the scientific community. The journal not only emphasizes innovative studies that bridge behavioral science and neuroscience but also serves as a platform for diverse methodologies and interdisciplinary approaches. Accessible [open access](https://onlinelibrary.wiley.com/journal/21623279), Brain and Behavior invites submissions that explore the neural mechanisms underlying behavior, aiming to engage a global audience eager to expand the boundaries of knowledge in this dynamic field. Positioned in the heart of the United States, at 111 River St, Hoboken, NJ, it is strategically placed to collaborate with leading institutions and researchers worldwide.

BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, a premier academic journal published by TAYLOR & FRANCIS LTD, stands at the forefront of interdisciplinary research in the fields of Biological Psychiatry, Psychiatry, and Mental Health. Based in the United Kingdom, this esteemed journal (ISSN: 1562-2975; E-ISSN: 1814-1412) has become increasingly influential since its inception in 2000, with a remarkable impact factor that reflects its high-quality research contributions. The journal is consistently ranked in the Q1 and Q2 categories across various relevant indices, demonstrating its reputation for excellence within the academic community. With Scopus rankings placing it in the top 20th percentile for Psychiatry and Mental Health, the WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY serves as a vital resource for researchers, professionals, and students seeking to further their understanding of the intricate relationship between biological processes and psychiatric phenomena. Despite being a traditional access journal, it possesses a robust scope that encompasses groundbreaking studies, reviews, and advancements in the understanding of mental health disorders, underlining its importance as a key reference in the advancement of psychiatric science and therapeutic practices.

Brain Behavior & Immunity-Health is a pioneering journal dedicated to advancing knowledge in the fields of nephrology and psychiatry, with a specific focus on the interplay between brain health and immune function. Published by Elsevier, this journal holds a prestigious Q1 ranking in both nephrology and psychiatry and mental health, underscoring its reputation for excellence within a competitive academic landscape. With an ISSN of 2666-3546, it provides a vital platform for researchers and professionals to disseminate cutting-edge findings and explore novel approaches to understanding the complex interactions between mental health and physical health dimensions. Available to readers in the United States and internationally, the journal not only supports open dialogue among scholars but also aims to foster interdisciplinary collaborations that address the critical challenges in these fields. As a part of its objectives, Brain Behavior & Immunity-Health is committed to highlighting transformative research that can lead to innovative strategies for healthcare, making it an essential resource for anyone seeking to expand their expertise in the intersection of behavioral health and immunology.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

Behavioural Pharmacology is a distinguished academic journal published by Lippincott Williams & Wilkins, focusing on the intricate relationship between pharmacology, psychiatry, and behavioral science. With an ISSN of 0955-8810 and an E-ISSN of 1473-5849, this journal serves as a vital platform for researchers and professionals dedicated to exploring the pharmacological mechanisms underlying behavior and mental health. Operating with a robust track record since its inception in 1992, it has established itself in the academic community, as reflected by its Q3 rankings in both the pharmacology and psychiatry categories for 2023. Additionally, the journal holds a credible position in Scopus rankings, with a percentile ranking indicative of significant contributions to the fields of pharmacology and psychiatry. Aimed at advancing knowledge and disseminating research in the behavioral pharmacology domain, this journal is an essential resource for students, researchers, and clinical professionals seeking to stay at the forefront of this rapidly evolving field. While it is not an open access journal, the rich content and research findings published here continue to foster collaboration and innovation within the community, making it a crucial reference point for current and future studies.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE is a distinguished publication in the field of Psychiatry and Mental Health, published by TAYLOR & FRANCIS LTD in the United Kingdom. With an impressive 2023 impact factor that places it in the Q2 category among its peers, this journal is an essential resource for researchers, clinicians, and students dedicated to advancing mental health practices and understanding psychiatric disorders. Covering topics from clinical studies to innovative treatment methodologies, the journal welcomes original research, reviews, and case studies that contribute valuable insights into clinical practice. Accessible without any open access restrictions, the journal has been a pivotal platform since its inception in 1997, facilitating knowledge exchange in the field up to 2024. As evidenced by its notable Scopus ranking within the top 73rd percentile of Psychiatry and Mental Health, it remains committed to impacting clinical practices significantly.